Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: NK-92 cells labeled with Fe3O4-PEG-CD56/Avastin@Ce6 nanoprobes for the targeted treatment and noninvasive therapeutic evaluation of breast cancer

Fig. 3

FCM analysis of Fe3O4-PEG-CD56/Avastin@Ce6 NP-labeled human NK-92 cells. (A) Rate of cell apoptosis via FCM analysis. (B) Statistical analysis of cell apoptosis in different groups. (C) Percentage of cells at different stages of the cell cycle by FCM analysis. (D) Statistical analysis of cell cycle in different groups. (E) Fluorescence images of NK cells with generation of ROS. (F) Statistical analysis of ROS signal fluorescence intensity in different groups

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us